Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


5th World Congress on Virology

Atlanta, USA

Masaaki Kawano

Masaaki Kawano

Saitama Medical University.Japan

Title: Medical application of a nanocapsule derived from a viral capsid protein


Biography: Masaaki Kawano


Development of protein-based delivery-carriers for diagnosis and therapy has progressed by using viral capsid protein. Simian virus 40 (SV40) is a small non-enveloped DNA virus of polyomaviridae. The capsid structure of SV40 is 45 nm in diameter and is formed by 72 copies of pentamers composed of five VP1 major capsid proteins (360 molecules in total). When expressed in insect cells using recombinant baculovirus, VP1 is self-assembled into virus-like particles (VLPs) of 45 nm in diameter as the naturally assembled SV40 virus capsid. VLPs isolated from the cells are disassembled in vitro into VP1-pentamers by the addition of DTT and EGTA. These VP1-pentamers are self-reassembled in vitro into VLPs under appropriate conditions. In this reassembly, VLPs can encapsulate various materials such as DNA and proteins. It is also possible to modify VP1 for providing VLPs with the ability of targeting of specific cell. It was recently indicated that SV40 VLPs could be a promising vaccine platform. Thus, VP1 has a great potential for developing a variety of nanocapsule for medical application. In this presentation, we summarize our technology using SV40 VP1 for medical application and show an application of SV40 VP1 as an efficient vaccine nanocapsule. Indeed, vaccination of SV40 VP1 nanocapsule inserted HLA-A2 restricted cytotoxic T lymphocyte (CTL) epitope of GILGFVFTL of influenza virus matrix protein 1 (M1) efficiently induced CTLs against M1 with fifty times more than classical incomplete freund’s adjuvant method.

Speaker Presentations

Speaker PPTs Click Here